Search
for
Sort by
Research 271–300 of 280
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- Dermatological manifestations of COVID-19 and its therapies: a review
- Androgenetic alopecia and coronavirus infection
- An overview of the genetic aspects of hair loss and its connection with nutrition
- Iron Deficiency in Menstruating Adult Women: Much More than Anemia
- Pica for Uncooked Basmati Rice in Two Women with Iron Deficiency and a Review of Ryzophagia
- Role of nutritional supplements in selected dermatological disorders: A review
- Iron deficiency and hair loss—Nothing new?
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- The necessity of holistic approach to treatment of telogen hair loss associated with iron deficiency in women
- Testosterone in COVID-19 – Foe, Friend or Fatal Victim?
- Repurposing existing drugs for COVID-19: an endocrinology perspective
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Spiking dependence of SARS‐CoV‐2 pathogenicity on TMPRSS2
- Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- ACE2 and TMPRSS2 Potential Involvement in Genetic Susceptibility to SARS-COV-2 in Cancer Patients
- Is COVID-19 Gender-sensitive?
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- An Assessment on Impact of COVID-19 Infection in a Gender Specific Manner
- Cutaneous signs in COVID ‐19 patients: A review
- Sex differences in COVID-19: the role of androgens in disease severity and progression
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Are sex discordant outcomes in COVID-19 related to sex hormones?
- Hair Loss and Androgen’s Role in the Era of COVID-19
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Redefining hormone resistance in prostate cancer